Neurocritical Care

, 6:56 | Cite as

Antihypertensive treatment of acute cerebral hemorrhage (ATACH)

Rationale and design
  • Adnan I. Qureshi
  • Antihypertensive Treatment of Acute Cerebral Hemorrhage Investigators
Taking a Closer Look at Trials

Abstract

This trial is a multicenter open-labeled pilot trial to determine the tolerability and safety of three escalating levels of antihypertensive treatment goals for acute hypertension in 60 subjects with supratentorial intracerebral hemorrhage (ICH). The pilot trial is the natural development of numerous case series evaluating the effect of antihypertensive treatment of acute hypertension in subjects with ICH. The proposed trial will have important public health implications by providing necessary information for a definitive phase III study regarding the efficacy of antihypertensive treatment of acute hypertension in subjects with ICH. The specific aims of the present pilot study are to: (1) Determine the tolerability of the treatment as assessed by achieving and maintaining three different systolic blood pressure goals with intravenous nicardipine infusion for 18 to 24 hours postictus in subjects with ICH who present within 6 hours of symptom onset; (2) Define the safety, assessed by the rate of neurological deterioration during treatment and serious adverse events, of three escalating systolic blood pressure treatment goals using intravenous nicardipine infusion; and (3) Obtain preliminary estimates of the treatment effect using the rate of hematoma expansion (within 24 hours) and modified, Rankin scale and Barthel index at 3 months following symptom onset.

References

  1. 1.
    Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30(4):905–915.PubMedGoogle Scholar
  2. 2.
    Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344(19):1450–1460.CrossRefPubMedGoogle Scholar
  3. 3.
    Broderick J, Brott T, Tomsick T, Tew J, Duldner J, Huster G. Management of intracerebral hemorrhage in a large metropolitan population. Neurosurgery 1994;34(5):882–887; discussion 887.CrossRefPubMedGoogle Scholar
  4. 4.
    Reed SD, Blough DK, Meyer K, Jarvik JG. Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. Neurology 2001;57(2):305–314.PubMedGoogle Scholar
  5. 5.
    Porsdal V, Boysen G. Direct costs during the first year after intracerebral hemorrhage. Eur J Neurol 1999;6(4):449–454.CrossRefPubMedGoogle Scholar
  6. 6.
    Holloway RG, Witter DM Jr, Lawton KB, Lipscomb J, Samsa G. Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology 1996;46(3):854–860.PubMedGoogle Scholar
  7. 7.
    Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke 1996;27(9):1459–1466.PubMedGoogle Scholar
  8. 8.
    Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001;57(1):18–24.PubMedGoogle Scholar
  9. 9.
    Qureshi AI, Giles WH, Croft JB. Racial differences, in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology 1999;52(8):1617–1621.PubMedGoogle Scholar
  10. 10.
    Nishiyama T, Yokoyama T, Matsukawa T, Hanaoka K. Continuous nicardipine infusion to control blood pressure after evacuation of acute cerebral hemorrhage. Can J Anaesth 2000;47(12): 1196–1201.CrossRefPubMedGoogle Scholar
  11. 11.
    Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981;246(19):2177–2180.CrossRefPubMedGoogle Scholar
  12. 12.
    Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993;43(3 Pt 1):461–467PubMedGoogle Scholar
  13. 13.
    Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg 1994;81(1):93–102.CrossRefPubMedGoogle Scholar
  14. 14.
    Bullock R, Brock-Utne J, van Dellen J, Blake G. Intracerebral hemorrhage in a primate model: effect on regional cerebral blood flow. Surg Neurol 1988;29(2):101–107.CrossRefPubMedGoogle Scholar
  15. 15.
    Nath FP, Kelly PT, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Effects of experimental intracerebral hemorrhage on blood flow, capillary permeability, and histochemistry. J Neurosurg 1987;66(4):555–562.CrossRefPubMedGoogle Scholar
  16. 16.
    Ropper AH, Zervas NT. Cerebral blood flow after experimental basal ganglia hemorrhage. Ann Neurol 1982;11(3):266–271.CrossRefPubMedGoogle Scholar
  17. 17.
    Brott T, Broderick J, Kothari R, et al. Early, hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28(1):1–5.PubMedGoogle Scholar
  18. 18.
    Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996;27(10):1783–1787.PubMedGoogle Scholar
  19. 19.
    Broderick JP, Brott TG, Tomsick T, Barsan W, Spilker J. Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg 1990; 72(2):195–199.CrossRefPubMedGoogle Scholar
  20. 20.
    Chen ST, Chen SD, Hsu CY, Hogan EL. Progression of hypertensive intracerebral hemorrhage. Neurology 1989;39(11):1509–1514.PubMedGoogle Scholar
  21. 21.
    Danadapani BK, Suzuki S, Kelley RE, Reyes-Iglesias, Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26(1):21–24.Google Scholar
  22. 22.
    Meyer JS, Bauer RB. Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology 1962;12:36–47.PubMedGoogle Scholar
  23. 23.
    Qureshi AI, Suri MF, Mohammad Y, Guterman LR, Hopkins LN. Isolated and borderline isolated systolic hypertension relative to long-term risk and type of stroke: a 20-year follow-up of the national health and nutrition survey. Stroke 2002;33(12):2781–2788.CrossRefPubMedGoogle Scholar
  24. 24.
    Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike, T, Tanaka R. Ultra-early rebleeding, in spontaneous subarachnoid hemorrhage. J Neurosurg 1996;84(1):35–42.CrossRefPubMedGoogle Scholar
  25. 25.
    Morfis L, Schwartz RS, Poulos R, Howes LG. Blood pressure changes in acute cerebral infarction and hemorrhage. Stroke 1997;28(7):1401–1405.PubMedGoogle Scholar
  26. 26.
    Qureshi AI, Geocadin RG, Suarez JI, Ulatowski JA. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med 2000;28(5):1556–1564.CrossRefPubMedGoogle Scholar
  27. 27.
    Qureshi AI, Mohammad YM, Yahia AM, et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med 2005:20(1):34–42.CrossRefPubMedGoogle Scholar
  28. 28.
    Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27(8):1304–1305.PubMedGoogle Scholar
  29. 29.
    Penny JA, Shennan AH, Halligan AW, Taylor DJ, de Swiet M, Anthony J. The relative accuracy of sequential same-arm and simultaneous opposite-arm measurements for the intra-arterial validation of blood pressure monitors. Blood Press Monit 1999;4(2):91–95.PubMedGoogle Scholar
  30. 30.
    Manolio TA, Fishel SC, Beattie C, et al. Evaluation of the Dinamap continuous blood pressure monitor. Am J Hypertens 1988;1(3 Pt 3): 161S-167S.PubMedGoogle Scholar
  31. 31.
    Tinker JH, Michenfelder JD. Sodium nitroprusside: pharmacology, toxicology and therapeutics. Anesthesiology 1976;45(3): 340–354.CrossRefPubMedGoogle Scholar
  32. 32.
    Prielipp RC, Wall MH, Groban L, eet al. Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers. Anesth Analg 2001;93(1):45–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Frakes MA. Esmolol: a unique drug with ED applications. J Emerg Nurs 2001;27(1):47–51.CrossRefPubMedGoogle Scholar
  34. 34.
    de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin ‘handicap’ grades after stroke. Stroke 1995;26(11):2027–2030.PubMedGoogle Scholar
  35. 35.
    Wolfe CD, Taub NA, Woodrow EJ, Burney PG. Assessment of scales of disability and handicap for stroke patients. Stroke 1991;22(10):1242–1244.PubMedGoogle Scholar
  36. 36.
    van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19(5):604–607.PubMedGoogle Scholar
  37. 37.
    Rankin J. Cerebral vascular accidents in patients over the age of 60. III. Diagnosis and treatment. Scott Med J 1957;2(6):254–268.PubMedGoogle Scholar
  38. 38.
    Shinar D, Gross CR, Bronstein, KS, et al. Reliability of the activities of daily living scale and its use in telephone interview. Arch Phys Med Rehabil 1987;68(10):723–728.PubMedGoogle Scholar
  39. 39.
    Granger CV, Dewis LS, Peters NC, Sherwood CC, Barrett JE. Stroke rehabilitation: analysis of repeated Barthel index measures. Arch Phys Med Rehabil 1979;60(1)14–17.PubMedGoogle Scholar
  40. 40.
    Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965;14:61–65.PubMedGoogle Scholar
  41. 41.
    Wallin JD, Fletcher E, Ram CV, et al. Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebocontrolled multicenter trial. Arch Intern Med 1989;149(12):2662–2669.CrossRefPubMedGoogle Scholar
  42. 42.
    Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 1999;27(3):480–485.CrossRefPubMedGoogle Scholar
  43. 43.
    Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic detectioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology 1994;44(8):1379–1384PubMedGoogle Scholar
  44. 44.
    Halpern NA, Goldberg M, Neely C, et al. Postoperative hypertension: a multicenter, prospective, randomized comparison betweene intravenous nicardipine and sodium nitroprusside. Crit Care Med 1992;20(12):1637–1643.CrossRefPubMedGoogle Scholar
  45. 45.
    Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. IV Nicardipine Study Group. Chest 1991;99(2):393–398.Google Scholar
  46. 46.
    Qureshi AI, Safdar K, Weil J, et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 1995;26(10):1764–1767.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Adnan I. Qureshi
    • 1
  • Antihypertensive Treatment of Acute Cerebral Hemorrhage Investigators
  1. 1.Clinical Research Division, Zeenat Qureshi Stroke Research Center, New Jersey Medical SchoolUniversity of Medicine and Dentistry of New JerseyNeward

Personalised recommendations